A monoclonal antibody-Pseudomonas toxin conjugate that specifically kills multidrug-resistant cells.
AUTOR(ES)
FitzGerald, D J
RESUMO
One form of multidrug resistance is due to the expression of a 170-kDa energy-dependent drug efflux pump called P-glycoprotein in the plasma membranes of human cancer cells. We have prepared conjugates of Pseudomonas toxin with the anti-P-glycoprotein monoclonal antibody MRK-16. These anti-P-glycoprotein-toxin conjugates specifically kill multidrug-resistant human KB cells. Similar conjugates could be useful in cancer therapy to reduce or eliminate multidrug-resistant tumor populations in tumors intrinsically resistant to chemotherapy or in populations that become resistant during combination chemotherapy.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=305070Documentos Relacionados
- Multidrug-resistant tuberculosis
- Amplification of DNA sequences in human multidrug-resistant KB carcinoma cells.
- Comparison of ion channels in multidrug-resistant and -sensitive human leukemic cells.
- ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells.
- Isolation and characterization of DNA sequences amplified in multidrug-resistant hamster cells.
